Pluristyx and Humacyte Announce Partnership
Pluristyx, a renowned cellular therapy developer, has partnered with Humacyte, a biotechnology company specializing in bioengineered human tissue. This...
Obsidian’s OBX-115 T-Cell Therapy For Melanoma Receives FDA Fast Track
Obsidian Therapeutics has secured Fast Track Designation from the FDA for OBX-115, an engineered T-cell therapy targeting metastatic or...
What You Need to Know About Clinical Trial Temperature Management Solutions
Maintaining drug stability and integrity is crucial in the rapidly advancing field of clinical trials and amidst global climate...
Remarkable Advances in EDC Systems You Need to Know
Zach Taft, CEO of health tech innovator Ignitedata, discusses the critical need for interoperability between Electronic Health Records (EHR)...
Antidote Strengthens Clinical Trial Enrollment Collaboration
SEQSTER and Antidote have revolutionized patient matching and clinical research efficiency. SEQSTER’s patient-centric healthcare platform provides a comprehensive view...
Genentech Unveils Second Chance for Susvimo to Combat AMD
The Food and Drug Administration (FDA) has approved updates to Susvimo, an eye implant treatment for wet age-related macular...
Human-Enabled AI Driving Enhancements in Clinical Trial Site Selection
Effective clinical trial site selection is crucial for the success of any clinical trial. It plays a pivotal role...
Genexine and EPD Bio Announce Merger, Paving the Way for Revolutionized Drug Development
Genexine, a Korean biopharmaceutical company, has merged with EPD Biotherapeutics, specializing in targeted protein degradation (TPD) technology. This merger...
Announcing Calidi’s Stock Split
Calidi Biotherapeutics has authorized a one-for-ten reverse stock split, effective July 15, 2024. The split will be applied to...
Acticor Biotech: Disclosure of Voting Rights, Shares May 2024
ACTICOR BIOTECH, a clinical-stage pharmaceutical company, reports its voting rights and shares as of May 31, 2024. The company...